News
News
- Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents
05/11/2021 / 08:30 - GlobeNewswire - BioNTech Announces First Quarter 2021 Financial Results and Corporate Update
05/10/2021 / 13:00 - GlobeNewswire - BioNTech to Establish Regional Headquarters for South East Asia and First mRNA Manufacturing Facility in Singapore
05/10/2021 / 07:31 - GlobeNewswire - Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for U.S. FDA Approval of their COVID-19 Vaccine
05/07/2021 / 12:45 - GlobeNewswire - Merus Announces Financial Results for the First Quarter and Provides Business Update
05/06/2021 / 23:14 - GlobeNewswire - Pfizer and BioNTech to Provide COVID-19 Vaccine Doses for Olympic Athletes at the 2020 Tokyo Games
05/06/2021 / 12:30 - GlobeNewswire - Genmab Announces Financial Results for the First Quarter of 2021
05/05/2021 / 17:01 - GlobeNewswire - BioNTech to Report First Quarter 2021 Financial Results and Operational Update on May 10, 2021
05/04/2021 / 13:02 - GlobeNewswire - Pfizer and BioNTech Submit Request to Expand Conditional Marketing Authorization of COMIRNATY® in the EU to Adolescents
04/30/2021 / 13:00 - GlobeNewswire - Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2021
04/20/2021 / 12:34 - GlobeNewswire
Real-time